Statins do not sway perioperative mortality in aortic repair, but confer long term survival gains


Following his first-to-podium presentation on statin treatment after aortic repair at the 2023 Charing Cross (CX) International Symposium (25–27 April, London, UK), Kevin Mani (Uppsala, Sweden) joined Janet Powell (London, UK) at the CX Vascular Live studio to discuss the new data, its implications and potential further research in the space. 

“Statin treatment did not affect perioperative mortality, but it did significantly affect improved long-term survival,” Mani stated in the studio, sharing one of the key findings from his presentation on a national study of patients undergoing aortic repair. However, he stressed that the dose of statin “did not affect mortality in-and-of itself”.


Please enter your comment!
Please enter your name here